Market Tracker

08/30 5:16pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.35
Delayed Data
As of 3:59pm ET
 +0.02 / +0.27%
Today’s Change
5.40
Today|||52-Week Range
10.74
-14.04%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close7.33
Today’s open7.27
Day’s range7.27 - 7.61
Volume59,188
Average volume (3 months)121,309
Market cap$96.3M
Dividend yield--
Data as of 3:59pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)-8.06%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.41

Competitors

 Today’s
change
Today’s
% change
SBBPStrongbridge Biophar...+0.34+7.54%
SBPHSpring Bank Pharmace...+0.25+2.00%
NVLSNivalis Therapeutics...+0.15+2.44%
EBIOEleven Biotherapeuti...-0.01-0.21%
Data as of 3:59pm ET, 08/30/2016

Financials

Next reporting dateNovember 23, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$7.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts